With recession indicators flashing, investors are flocking to 10-year bonds that have the annual upside of just 1.5%.
But there are still market-beating stocks out there – in fact, one of our picks expects 103% growth.
And that brings us to the biotech industry.
There are some big biotech stocks to own right now that could deliver double, even triple-digit upside in less than 12 months.